James K. Hammitt

James K. Hammitt is professor of economics and decision sciences at Harvard University (Center for Risk Analysis) and at the Toulouse School of Economics (LERNA-INRA).

Are We Making Progress in Valuing Health and Longevity in Regulatory Analysis?

Are We Making Progress in Valuing Health and Longevity in Regulatory Analysis?

Although agencies have made strides concerning values for mortality risk reductions, more research is needed on these values.

Updating the Benefits of Preventing Acute Illness

Updating the Benefits of Preventing Acute Illness

New research finds higher values for protection against risks of short-term foodborne illness.

New Recommendations for Valuing Mortality Risk Reductions

New Recommendations for Valuing Mortality Risk Reductions

EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.